Clinical Trial: ALSO-PERFORM Study. ALternating Stereotaxic Or PElvic Radiotherapy FOR Metachronic Metastatic Prostate Cancer

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863336) titled 'ALSO-PERFORM Study. ALternating Stereotaxic Or PElvic Radiotherapy FOR Metachronic Metastatic Prostate Cancer' on Oct. 01.

Brief Summary: Outcome of metastasis directed therapy

Study Start Date: Jan. 01, 2027

Study Type: OBSERVATIONAL

Condition: Prostate Cancer

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Amsterdam UMC, location VUmc

Information provided by (Responsible Party): Prof. Dr. Andre N. Vis, Amsterdam UMC, location VUmc

Published by HT Digital Content Services with permission from Health Daily Digest....